menu
    • menu

    Company profile for Noven Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. We are committed to developing and offering products and technologies that meaningfully benefit patients, our customers and our industry partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Noven PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Noven11960 SW 144th StreetMiami, FL 33186
    Telephone
    Telephone
    305-253-5099
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.noven.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innovent's Cancer Drug Receives Special Development Status
    Innovent's Cancer Drug Receives Special Development Status

    15 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-receives-nmpa-breakthrough-therapy-designation-for-ibi343-anti-cldn18-2-adc-as-monotherapy-for-advanced-pancreatic-cancer-302352458.html

    PR NEWSWIRE
    15 Jan 2025
    Share Share
    Noven Debuts ADHD Mindful Patch Companion App at APSARD 2025
    Noven Debuts ADHD Mindful Patch Companion App at APSARD 2025

    14 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250114916087/en

    BUSINESSWIRE
    14 Jan 2025
    Share Share
    Innovent to Present Data on Novel Molecules at ESMO Asia 2024
    Innovent to Present Data on Novel Molecules at ESMO Asia 2024

    24 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-to-present-clinical-data-of-multiple-novel-molecules-at-esmo-asia-2024-302314905.html

    PR NEWSWIRE
    24 Nov 2024
    Share Share
    Innovent Ph 2 Of Picankibart In Ulcerative Colitis Met Endpoint
    Innovent Ph 2 Of Picankibart In Ulcerative Colitis Met Endpoint

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-announces-phase-2-clinical-study-of-picankibart-ibi112-in-chinese-patients-with-ulcerative-colitis-met-primary-endpoint-302277657.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    Enforcement Report - Week of March 29, 2023
    Enforcement Report - Week of March 29, 2023

    29 Mar 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-29-2023-93363.pdf

    FDA
    29 Mar 2023
    Share Share
    XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD
    XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD

    10 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xelstrym-dextroamphetamine-transdermal-system-cii-to-be-revealed-as-available-soon-at-the-2023-american-professional-society-of-adhd-and-related-disorders-apsard-conference-301717624.html

    PR NEWSWIRE
    10 Jan 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search